NextCure, Inc. (NXTC)

NextCure Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	15.26	25.98	27.73	13.08	26.63	12.34
Short-Term Investments	4.83	15.84	40.89	95.22	133.28	207.25
Cash & Short-Term Investments	20.09	41.82	68.62	108.3	159.91	219.59
Cash Growth	-43.11%	-39.06%	-36.64%	-32.27%	-27.18%	-22.53%
Other Receivables	0.1	0.1	0.3	0.8	0.7	-
Receivables	0.1	0.1	0.3	0.8	0.7	-
Prepaid Expenses	2.07	1.83	2.89	3.63	3.37	8.23
Total Current Assets	22.26	43.75	71.81	112.73	163.98	227.82
Property, Plant & Equipment	0.28	5.89	8.72	13.43	16.91	13.99
Other Long-Term Assets	0.08	0.55	0.33	1.88	3.27	0.58
Total Assets	22.62	50.18	80.86	128.04	184.16	242.39

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	2.58	2.01	5.35	2.33	4.27	1.94
Accrued Expenses	2.77	2.42	3.3	3.78	4.23	4.45
Current Portion of Leases	1.06	1.01	0.8	0.66	0.52	-
Other Current Liabilities	-	5.14	0.12	0.11	0.11	0.22
Total Current Liabilities	6.41	10.57	9.57	6.88	9.13	6.61
Long-Term Leases	3.6	4.15	5.15	5.95	6.61	-
Other Long-Term Liabilities	0.46	0.53	0.66	0.79	0.9	2.39
Total Liabilities	10.47	15.24	15.39	13.62	16.63	9

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0	0	0	0.03	0.03	0.03
Additional Paid-In Capital	472.82	470.9	445.6	439.1	430.76	421.05
Retained Earnings	-460.67	-435.98	-380.14	-324.48	-261.76	-187.03
Comprehensive Income & Other	-0	0.02	0	-0.22	-1.49	-0.66
Total Common Equity	12.15	34.94	65.47	114.42	167.53	233.39
Shareholders' Equity	12.15	34.94	65.47	114.42	167.53	233.39
Total Liabilities & Equity	22.62	50.18	80.86	128.04	184.16	242.39

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	4.67	5.15	5.95	6.61	7.12	-
Net Cash (Debt)	15.42	36.67	62.67	101.69	152.79	219.59
Net Cash Growth	-48.11%	-41.50%	-38.37%	-33.44%	-30.42%	-21.57%
Net Cash Per Share	3.58	12.90	26.89	43.84	66.08	95.42
Filing Date Shares Outstanding	4.58	3.56	2.33	2.33	2.31	2.31
Total Common Shares Outstanding	4.07	3.51	2.33	2.33	2.31	2.31
Working Capital	15.84	33.18	62.23	105.84	154.86	221.21
Book Value Per Share	2.99	9.97	28.05	49.21	72.38	101.18
Tangible Book Value	12.15	34.94	65.47	114.42	167.53	233.39
Tangible Book Value Per Share	2.99	9.97	28.05	49.21	72.38	101.18
Machinery	-	19.24	19.24	19.73	18.34	17.79
Construction In Progress	-	-	-	0.23	0.85	0.37
Leasehold Improvements	-	9.31	9.31	9.31	9.34	8.57

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: May 7, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 27, 2026

Data Sources Report a data error